Skip to content
Clinical Trials – home

Universitaetsklinikum Duesseldorf AöR

Verifiedinfo

Germany Moorenstrasse 5, Bilk, 40225 Duesseldorf, Germany

  • 142 trials recruiting
  • Breast cancer · Acute myeloid leukaemia · Cholangiocarcinoma
  • Adults and children

About Specializations

Universitaetsklinikum Duesseldorf AöR in Duesseldorf, Germany specialises in clinical trials of conditions such as Breast cancer, Acute myeloid leukaemia, Cholangiocarcinoma, Plasma cell myeloma, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Research at Universitaetsklinikum Duesseldorf AöR

Clinical research at this hospital focuses on nervous system diseases, with a strong emphasis on multiple sclerosis and related neurological conditions. The studies are centered on understanding how new or emerging therapies may support long-term disease management and patient care.

  • Focus on neurology and broader nervous system diseases
  • Research in multiple sclerosis, including relapsing and progressive forms
  • Trials aimed at evaluating the safety and tolerability of treatment approaches

With 3 clinical trials and a large team of 76 investigators, the site contributes to ongoing efforts to improve treatment options and long-term outcomes for people living with neurological disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Moorenstrasse 5, Bilk40225 DuesseldorfGermany
Recruiting now
142 trials
Conditions studied
215
Partner status
Verified

More sites in DuesseldorfGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

316 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:GSK5764227
  • Sponsor:Glaxosmithkline Research & Development Limited
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Leo Pharma A/S
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Scleroderma Research Foundation
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cabotegravir
  • Sponsor:Gilead Sciences Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.